Zodasiran significantly reduced triglycerides and atherogenic triglyceride rich lipoproteins across all dose levels at Week 24 Data presented at European Atherosclerosis Society 92nd Congress and
- Plozasiran significantly lowered triglyceride levels with commensurate reductions in APOC3, non-HDL-C, and remnant cholesterol
- Data presented at European Atherosclerosis Society 92nd Congress.
In celebration of the Heart Month of February, healthcare company Organon Philippines is spearheading the Heart 2 heart talk on optimal cholesterol control, focused on raising public awareness about effectively managing Dyslipidemia and how Filipinos can protect their heart from the long-term impacts of high cholesterol levels.
Heart to Heart: Organon Spearheads Health Forum on Optimal Cholesterol Control manilastandard.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from manilastandard.net Daily Mail and Mail on Sunday newspapers.